Crystal structure of 3-[(3, 4-dinitro-1H-pyrazol-1-yl)-NNO-azoxy]-4-nitro-1, 2, 5-oxadiazole. Issue 3 (September 2021)

• Record Type: Journal Article
• Authors: Dmitrienko, A. O.; Konnov, A. A.; Klenov, M. S.
• Is Part Of: Powder diffraction. Volume 36:Issue 3(2021)
• Page Start: 176
• Page End: 180
• Publication Date: 2021-09
• Subjects: Rietveld refinement -- DFT calculations -- high-energy density materials; Powder metallurgy -- Periodicals; Materials -- Analysis -- Periodicals; 620.1127
• DOI: 10.1017/S0885715621000233
• Languages: English
• ISSNs: 0885-7156

Abstract

Abstract : The crystal structure of a novel high-energy density material 3-[(3, 4-dinitro-1 H -pyrazol-1-yl)- NNO -azoxy]-4-nitro-1, 2, 5-oxadiazole C5 HN9 O8 was determined and refined using laboratory powder diffraction data. The diffraction data and database analysis were insufficient to distinguish two candidate structures from the solution step. Density functional theory with periodic boundary conditions optimizations were used to choose the correct one. 3-[(3, 4-Dinitro1 H -pyrazol-1-yl)- NNO -azoxy]-4-nitro-1, 2, 5-oxadiazole crystallizes in space group Pbca with a = 8.3104(2) Å, b = 14.2198(5) Å, c = 19.4264(7) Å, V = 2295.66(14) Å 3 . The molecular conformation contains a weak intramolecular hydrogen bond C–H⋯O–N, and the structure is dominated by weak O⋯π and O⋯O contacts.